The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says

Neutral

AI Analysis

Summary

Fujifilm Biotechnologies CEO Lars Petersen comments on the approaching patent cliff and notes that 2026 has seen increased dealmaking activity. CDMOs are preparing to broaden services to support drugmakers navigating patent expirations.

Importance:3/10

Sentiment:

0.00

patent cliffCDMOcontract manufacturingdealmakingindustry analysis

Read the original article

Published by Endpoints News on July 27, 2026 6:30 PM

Read Original